feed,title,long_url,short_url
Benzinga,Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids,https://benzinga.com/general/biotech/23/03/31256303/mesoblasts-lead-drug-candidate-goes-under-fda-priority-review-for-bone-marrow-transplant-complica,https://da.gd/8euVk
